Corrigendum to "Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy" [Mol. Genet. Metab. 84 (2005) 144-151] (DOI:10.1016/j.ymgme.2004.09.015);Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy

Molecular Genetics and Metabolism

Volumn 84, Issue 2, 2005, Pages 144-151

  Kemp, Stephan ^a   Valianpour, Fredoen ^a   Denis, Simone ^a   Ofman, Rob ^a   Sanders, Robert Jan ^a   Mooyer, Petra ^a   Barth, Peter G ^a   Wanders, Ronald J A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Elongation; Lorenzo's oil; Peroxisome; Stable isotope; Very long chain fatty acids; VLCFA; X linked adrenoleukodystrophy; Oxidation

Indexed keywords

CARBON; LIPID; LORENZO OIL; VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ARTICLE; BIOGENESIS; BLOOD ANALYSIS; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISORDERS OF PEROXISOMAL FUNCTIONS; FATTY ACID SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; MALE; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RETROSPECTIVE STUDY;

EID: 12844267552     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2004.09.018     Document Type: Erratum

References (39)

1. H.W. Moser, K.D. Smith, P.A. Watkins, J. Powers, and A.B. Moser X-linked adrenoleukodystrophy C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Bases of Inherited Disease 2001 McGraw Hill New York 3257 3301
2. L. Bezman, A.B. Moser, G.V. Raymond, P. Rinaldo, P.A. Watkins, K.D. Smith, N.E. Kass, and H.W. Moser Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening Ann. Neurol. 49 2001 512 517
3. H.W. Moser, A.B. Moser, K.K. Frayer, W. Chen, J.D. Schulman, B.P. O'Neill, and Y. Kishimoto Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids Neurology 31 1981 1241 1249
4. A.B. Moser, N. Kreiter, L. Bezman, S. Lu, G.V. Raymond, S. Naidu, and H.W. Moser Plasma very long chain fatty acids in 3000 peroxisome disease patients and 29,000 controls Ann. Neurol. 45 1999 100 110
5. F. Valianpour, J.J. Selhorst, L.E. van Lint, A.H. van Gennip, R.J. Wanders, and S. Kemp Analysis of very long-chain fatty acids using electrospray ionization mass spectrometry Mol. Genet. Metab. 79 2003 189 196
6. P. Sharp, D. Johnson, and A. Poulos Molecular species of phosphatidylcholine containing very long chain fatty acids in human brain: enrichment in X-linked adrenoleukodystrophy brain and diseases of peroxisome biogenesis brain J. Neurochem. 56 1991 30 37
7. F.R. Brown III, M.A. Van Duyn, A.B. Moser, J.D. Schulman, W.B. Rizzo, R.D. Snyder, J.V. Murphy, S. Kamoshita, C.J. Migeon, and H.W. Moser Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids Johns Hopkins Med. J. 151 1982 164 172
8. S. Tsuji, T. Sano-Kawamura, T. Ariga, and T. Miyatake Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) J. Neurol. Sci. 71 1985 359 367
9. W.B. Rizzo, P.A. Watkins, M.W. Phillips, D. Cranin, B. Campbell, and J. Avigan Adrenoleukodystrophy: oleic acid lowers fibroblast saturated C22-26 fatty acids Neurology 36 1986 357 361
10. W.B. Rizzo, J. Avigan, J. Chemke, and J.D. Schulman Adrenoleukodystrophy: very long-chain fatty acid metabolism in fibroblasts Neurology 34 1984 163 169
11. O. Lazo, M. Contreras, A. Bhushan, W. Stanley, and I. Singh Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency Arch. Biochem. Biophys. 270 1989 722 728
12. M. Hashmi, W. Stanley, and I. Singh Lignoceroyl-CoASH ligase: enzyme defect in fatty acid beta-oxidation system in X-linked childhood adrenoleukodystrophy FEBS Lett. 196 1986 247 250
13. J. Mosser, A.M. Douar, C.O. Sarde, P. Kioschis, R. Feil, H. Moser, A.M. Poustka, J.L. Mandel, and P. Aubourg Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters Nature 361 1993 726 730
14. S.J. Steinberg, S. Kemp, L.T. Braiterman, and P.A. Watkins Role of very-long-chain acyl-coenzyme A synthetase in X-linked adrenoleukodystrophy Ann. Neurol. 46 1999 409 412
15. K.D. Smith, S. Kemp, L.T. Braiterman, J.F. Lu, H.M. Wei, M. Geraghty, G. Stetten, J.S. Bergin, J. Pevsner, and P.A. Watkins X-linked adrenoleukodystrophy: genes, mutations, and phenotypes Neurochem. Res. 24 1999 521 535
16. M.C. McGuinness, H.P. Zhang, and K.D. Smith Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy Mol. Genet. Metab. 74 2001 256 263
17. S.J. Wakil Fatty acid synthase, a proficient multifunctional enzyme Biochemistry 28 1989 4523 4530
18. A.E. Leonard, S.L. Pereira, H. Sprecher, and Y.S. Huang Elongation of long-chain fatty acids Progr. Lipid Res. 43 2004 36 54
19. D.H. Nugteren The enzymic chain elongation of fatty acids by rat-liver microsomes Biochim. Biophys. Acta 106 1965 280 290
20. Y. Kishimoto, H.W. Moser, N. Kawamura, M. Platt, S.L. Pallante, and C. Fenselau Adrenoleukodystrophy: evidence that abnormal very long chain fatty acids of brain cholesterol esters are of exogenous origin Biochem. Biophys. Res. Commun. 96 1980 69 76
21. W.B. Rizzo, R.T. Leshner, A. Odone, A.L. Dammann, D.A. Craft, M.E. Jensen, S.S. Jennings, S. Davis, R. Jaitly, and J.A. Sgro Dietary erucic acid therapy for X-linked adrenoleukodystrophy Neurology 39 1989 1415 1422
22. A.B. Moser, J. Borel, A. Odone, S. Naidu, D. Cornblath, D.B. Sanders, and H.W. Moser A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients Ann. Neurol. 21 1987 240 249
23. G. Uziel, E. Bertini, P. Bardelli, M. Rimoldi, and M. Gambetti Experience on therapy of adrenoleukodystrophy and adrenomyeloneuropathy Dev. Neurosci. 13 1991 274 279
24. B.M. van Geel, J. Assies, E.B. Haverkort, J.H. Koelman, B. Verbeeten, R.J. Wanders, and P.G. Barth Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil" J. Neurol. Neurosurg. Psychiatry 67 1999 290 299
25. H. Dreyfus, B. Guerold, L. Freysz, and D. Hicks Successive isolation and separation of the major lipid fractions including gangliosides from single biological samples Anal. Biochem. 249 1997 67 78
26. S. Tsuji, T. Sano, T. Ariga, and T. Miyatake Increased synthesis of hexacosanoic acid (C26:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) J. Biochem. (Tokyo) 90 1981 1233 1236
27. S. Tsuji, T. Ohno, T. Miyatake, A. Suzuki, and T. Yamakawa Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy(ALD) J. Biochem. (Tokyo) 96 1984 1241 1247
28. M.C. McGuinness, J.F. Lu, H.P. Zhang, G.X. Dong, A.K. Heinzer, P.A. Watkins, J. Powers, and K.D. Smith Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy Mol. Cell. Biol. 23 2003 744 753
29. J.F. Lu, A.M. Lawler, P.A. Watkins, J.M. Powers, A.B. Moser, H.W. Moser, and K.D. Smith A mouse model for X-linked adrenoleukodystrophy Proc. Natl. Acad. Sci. USA 94 1997 9366 9371
30. P. Tvrdik, A. Asadi, L.P. Kozak, J. Nedergaard, B. Cannon, and A. Jacobsson Cig30, a mouse member of a novel membrane protein gene family, is involved in the recruitment of brown adipose tissue J. Biol. Chem. 272 1997 31738 31746
31. P. Tvrdik, R. Westerberg, S. Silve, A. Asadi, A. Jakobsson, B. Cannon, G. Loison, and A. Jacobsson Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids J. Cell Biol. 149 2000 707 718
32. C.S. Oh, D.A. Toke, S. Mandala, and C.E. Martin ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation J. Biol. Chem. 272 1997 17376 17384
33. G.C. Korenke, D.H. Hunneman, J. Kohler, S. Stockler, K. Landmark, and F. Hanefeld Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical biochemical and neurophysiological parameters Eur. J. Pediatr. 154 1995 64 70
34. P. Aubourg, C. Adamsbaum, M.C. Lavallard-Rousseau, F. Rocchiccioli, N. Cartier, I. Jambaque, C. Jakobezak, A. Lemaitre, F. Boureau, and C. Wolf A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy N. Engl. J. Med. 329 1993 745 752
35. A. Poulos, R. Gibson, P. Sharp, K. Beckman, and P. Grattan-Smith Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil Ann. Neurol. 36 1994 741 746
36. P.G. Barth, M. Martinez, P. Apkarian, E.B. Haverkort, R.J. Wanders, and R.B. Schutgens Disorders of peroxisome biogenesis: classification and treatment R.J. Wanders R.B. Schutgens H.F. Tabak Functions and Biogenesis of Peroxisomes in Relation to Human Disease 1995 Elsevier Publishers Amsterdam 201 226
37. R.A. Knazek, W.B. Rizzo, J.D. Schulman, and J.R. Dave Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy J. Clin. Invest 72 1983 245 248
38. J.K. Ho, H. Moser, Y. Kishimoto, and J.A. Hamilton Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy J. Clin. Invest. 96 1995 1455 1463
39. H.W. Moser, G.V. Raymond, W. Koehler, P. Sokolowski, F. Hanefeld, G.C. Korenke, A. Green, D.J. Loes, D.H. Hunneman, R.O. Jones, S.E. Lu, G. Uziel, M.L. Giros, and F. Roels Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials Adv. Exp. Med. Biol. 544 2003 369 387